JPRN-C000000335已完成3 期
A Randomized Phase III trial of Paclitaxel plus Cisplatin versus Paclitaxel plus Carboplatin in Stage IVB, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3) - A Randomized Phase III trial of Paclitaxel plus Cisplatin versus Paclitaxel plus Carboplatin in Stage IVB, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 250 人开始时间: 2006年2月21日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) patients who have some neurologically functional disorder 2) symptomatic CNS metastasis 3) hypersensitive to alcohol 4) active infection 5) HBs antigen positive 6) uncontrollable hypertension 7) history of myocardiac infarction within six months 8) unstable angina 9) uncontrollable diabetes 10) Patients with a concomitant or prior invasive malignancy (except intramucosal malignancy which are curable with local therapy) who have had any evidence of the disease within the last 5 years 11) women during pregnancy or breast-feeding 12) patients with psychiatric liiness 13) patients who have been treated with the systemic steroids medication
研究者
相似试验
已完成
3 期
Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)Stage III colorectal cancerJPRN-C000000193Japan Clinical Oncology Group(JCOG)1,100
已完成
3 期
A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)extensive-disease small cell lung cancerJPRN-UMIN000000720Japan Clinical Oncology Group(JCOG)282
已完成
3 期
Paclitaxel plus carboplatin (TC) therapy versus irinotecan plus cisplatin (CPT-P) therapy as a first-line chemotherapy in clear cell ovarian cancerOvarian cancerTopic: National Cancer Research NetworkSubtopic: Gynaecological CancerDisease: OvaryCancerISRCTN52615671Greater Glasgow Health Board (North Glasgow University Hospitals Division) (UK)667
已完成
3 期
Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207)non-small-cell lung cancerJPRN-C000000146Japan Clinical Oncology Group(JCOG)230
已完成
3 期
Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)non-small-cell lung cancerJPRN-UMIN000001424Japan Clinical Oncology Group(JCOG)380